- Home
- SOPH vs ANGO Comparison
SOPH vs ANGO Comparison
Compare SOPH & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOPH | ANGO |
|---|---|---|
| Founded | 2011 | 1988 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.7M | 427.0M |
| IPO Year | 2021 | 2004 |
Fundamental Metrics
Financial Performance| Metric | SOPH | ANGO |
|---|---|---|
| Price | $4.74 | $10.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $7.00 | ★ $19.33 |
| AVG Volume (30 Days) | 361.7K | ★ 482.7K |
| Earning Date | 03-03-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $73,297,000.00 | ★ $307,306,000.00 |
| Revenue This Year | $18.48 | $9.11 |
| Revenue Next Year | $15.82 | $4.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.66 | 7.26 |
| 52 Week Low | $2.58 | $8.27 |
| 52 Week High | $5.70 | $13.99 |
Technical Indicators
Market Signals| Indicator | SOPH | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 42.03 | 51.03 |
| Support Level | $4.61 | $10.66 |
| Resistance Level | $5.06 | $11.78 |
| Average True Range (ATR) | 0.31 | 0.48 |
| MACD | -0.06 | 0.17 |
| Stochastic Oscillator | 13.73 | 60.29 |
Price Performance
Historical ComparisonAbout SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.